Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin in Perinatal Asphyxia
NCT02002039Phase 3Completed
- Sponsor
- Sher-i-Kashmir Institute of Medical Sciences
- Start
- Jun 2012
- Primary completion
- Jun 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of erythropoietin in perinatal asphyxia, hypoxic-ischemic encephalopathy (HIE), sponsored by Sher-i-Kashmir Institute of Medical Sciences. Started Jun 2012; status: completed.
02
Drugs
erythropoietin
03
Conditions
perinatal asphyxiahypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT02002039.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02002039.